Premium Fentanyl Citrate 2500mcg/50ml Injection

Fentanyl Citrate 2500mcg/50ml is a synthetic opioid that is chemically designed to interact with the body’s opioid receptors. Buy Fentanyl Citrate 2500mcg/50ml Online from Inspired Ingniter and enjoy this interaction that leads to significant pain relief and is used in various medical scenarios, including anesthesia and pain management. Buy Fentanyl Online

Fentanyl vials is available in the solid dose form of fentanyl citrate, which is a sweetened lozenge on a stick.

Buy Fentanyl Citrate 2500mcg/50ml Online

Only use 200mcg and higher doses for anesthesia. A bolus injection of 10 ml of fentanyl produces analgesia that lasts for roughly an hour.

100 mcg of fentanyl are about equivalent to 157 mcg of fentanyl citrate. It dissolves in water easily (1 g in 40 mL) and alcohol only slightly. Fentanyl injection has a pH between 4.0 and 7.5.

Fentanyl Citrate 2500mcg/50ml Product Specifications

Effects Of Fentanyl Citrate 2500mcg/50ml

The safety of fentanyl IV was evaluated in 376 subjects who participated in 20 clinical trials evaluating fentanyl IV as an anaesthetic. These subjects took at least 1 dose of fentanyl IV and provided safety data. Based on pooled safety data from these clinical trials, the most commonly reported (≥5% incidence) Adverse Drug Reactions (ADRs) were (with % incidence): nausea (26.1); vomiting (18.6); muscle rigidity (10.4); hypotension (8.8); hypertension (8.8); bradycardia (6.1); and sedation (5.3).

Including the above-mentioned ADRs, Table 1 displays ADRs that have been reported with the use of fentanyl IV from either clinical trials or postmarketing experience.

The displayed frequency categories use the following convention: Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); and not known (cannot be estimated from the available clinical trial data).

Why Buy Fentanyl Citrate 2500mcg/50ml Online From Inspired Ingniter

Finding Reputable Online Pharmacies

Here at Inspired Ingniter we are a well-established, licensed pharmacies with a proven track record of selling authentic medications.

Ensuring Product Authenticity And Quality

Here at Inspired Ingniter you can verify the authenticity and quality of the product by checking for proper certifications and product descriptions. Authenticity is critical, as counterfeit products can be dangerous.

Reading And Interpreting Customer Reviews

Here at Inspired Ingniter we provide customer reviews which provide insights into the reliability of our online pharmacy and the quality of the product. Look for pharmacies with positive feedback and a history of satisfied customers.

Customer Service And Support Features

Good customer service is crucial. Our online shop offers prompt support, clear return policies, and responsive customer service.

Competitive Prices And Product Range

Compare prices and product ranges across different retailers to get the best deals. At Inspired Ingniter we offer the best competitive prices and a wide range of product options.

Trusted Retailers And Discreet Delivery

Several online pharmacies specialize in selling Fentanyl Citrate and other medications. Research these retailers to find those with the best reputation and customer service. Here at Inspired Ingniter we are very trustworthy and we offer discreet delivery to your doorstep without any problem.

Warnings About Fentanyl Citrate 2500mcg/50ml

Following intravenous administration of fentanyl, a transient fall in blood pressure may occur, especially in hypovolemic patients. Appropriate measures to maintain a stable arterial pressure should be taken.

Tolerance and Opioid use disorder (abuse and dependence)

For all patients, prolonged use of this product may lead to drug dependence (addiction), even at therapeutic doses.

Repeated use of opioids may lead to Opioid use disorder (OUD). Abuse or intentional misuse of opioids may result in overdose and/or death. The risk of developing OUD is increased in patients with a personal or a family history (parents or siblings) of substance use disorders (including alcohol use disorder), in current tobacco users or in patients with a personal history of other mental health disorders (e.g. major depression, anxiety and personality disorders).

Additional support and monitoring may be necessary when prescribing for patients at risk of opioid misuse.

A comprehensive patient history should be taken to document concomitant medications, including over- the-counter medicines and medicines obtained on-line, and past and present medical and psychiatric conditions.

Patients may find that treatment is less effective with chronic use and express a need to increase the dose to obtain the same level of pain control as initially experienced. Patients may also supplement their treatment with additional pain relievers. These could be signs that the patient is developing tolerance.

The risks of developing tolerance should be explained to the patient.

Overuse or misuse may result in overdose and/or death. It is important that patients only use medicines that are prescribed for them at the dose they have been prescribed and do not give this medicine to anyone else.

Patients should be closely monitored for signs of misuse, abuse, or addiction. The clinical need for analgesic treatment should be reviewed regularly.

Drug Withdrawal Syndrome

Prior to starting treatment with any opioids, a discussion should be held with patients to put in place a withdrawal strategy for ending treatment with fentanyl.

Drug withdrawal syndrome may occur upon abrupt cessation of therapy or dose reduction. When a patient no longer requires therapy, it is advisable to taper the dose gradually to minimise symptoms of withdrawal. Tapering from a high dose may take weeks to months.

The opioid drug withdrawal syndrome is characterised by some or all of the following: restlessness, lacrimation, rhinorrhoea, yawning, perspiration, chills, myalgia, mydriasis and palpitations. Other symptoms may also develop including irritability, agitation, anxiety, hyperkinesia, tremor, weakness, insomnia, anorexia, abdominal cramps, nausea, vomiting, diarrhoea, increased blood pressure, increased respiratory rate or heart rate.

If women receive this drug during pregnancy, there is a risk that their newborn infants will experience neonatal withdrawal syndrome.

Respiratory Depression

As with all potent opioids, profound analgesia is accompanied by marked respiratory depression, which may persist into or recur in the early postoperative period. Care should be taken after large doses or infusions of fentanyl to ensure that adequate spontaneous breathing has been established and maintained before discharging the patient from the recovery area.

Significant respiratory depression will occur following the administration of fentanyl in doses in excess of 200 micrograms. This, and the other pharmacological effects of fentanyl, can be reversed by specific opioid antagonists, but additional doses may be necessary because the respiratory depression may last longer than the duration of action of the opioid antagonist.

Resuscitation equipment and opioid antagonists should be readily available.

Hyperventilation during anesthesia may alter the patient’s response to CO₂, thus affecting respiration postoperatively.

Administration in labour may cause respiratory depression in the new-born infant.

Hyperalgesia

Hyperalgesia may be diagnosed if the patient on long-term opioid therapy presents with increased pain. This might be qualitatively and anatomically distinct from pain related to disease progression or to breakthrough pain resulting from development of opioid tolerance. Pain associated with hyperalgesia tends to be more diffuse than the pre-existing pain and less defined in quality. Symptoms of hyperalgesia may resolve with a reduction of opioid dose.

Risk from concomitant use of sedative medicines such as benzodiazepines or related drugs

Concomitant use of fentanyl and sedative medicines such as benzodiazepines or related drugs may result in sedation, respiratory depression, coma and death. Because of these risks, concomitant prescribing with these sedative medicines should be reserved for patients for whom alternative treatment options are not possible. If a decision is made to prescribe fentanyl concomitantly with sedative medicines, the lowest effective dose should be used, and the duration of treatment should be as short as possible.

The patients should be followed closely for signs and symptoms of respiratory depression and sedation. In this respect, it is strongly recommended to inform patients and their caregivers to be aware of these symptoms (see section 4.5).

Cardiac Disease

Bradycardia, and possibly cardiac arrest, can occur if the patient has received an insufficient amount of anticholinergic, or when fentanyl is combined with non-vagolytic muscle relaxants. Bradycardia can be antagonised by atropine.

Muscle Rigidity

Muscular rigidity (morphine-like effect) may occur.

Rigidity, which may also involve the thoracic muscles, can be avoided by the following measures:

− slow IV injection (usually sufficient for lower doses);

− premedication with benzodiazepines;

− use of muscle relaxants.

Non-epileptic (myo)clonic movements can occur.

Precautions About Fentanyl Citrate 2500mcg/50ml

Fentanyl should be given only in an environment where the airway can be controlled and by personnel who can control the airway.

Special Dosing Conditions

The use of rapid bolus injections of opioids should be avoided in patients with compromised intracerebral compliance; in such patients the transient decrease in the mean arterial pressure has occasionally been accompanied by a transient reduction of the cerebral perfusion pressure.

It is recommended to reduce dosage in the elderly and debilitated patients. In uncontrolled hypothyroidism, pulmonary disease, decreased respiratory reserve, alcoholism and hepatic or renal impairment the dosage should be titrated with care and prolonged post-operative monitoring is required.

Patients on chronic opioid therapy or with a history of opioid abuse may require higher doses.

Myasthenia Gravis

In patients with myasthenia gravis, careful consideration should be applied in the use of certain anticholinergic agents and neuromuscular-blocking pharmaceutical agents prior to, and during, the administration of a general anaesthetic regimen which includes administering intravenous fentanyl.

Interaction with neuroleptics

If fentanyl is administered with a neuroleptic, the user should be familiar with the special properties of each drug, particularly the difference in duration of action. When such a combination is used, there is a higher incidence of hypotension. Neuroleptics can induce extrapyramidal symptoms that can be controlled with anti-Parkinson agents.

Bile Duct

As with other opioids, due to the anticholinergic effects administration of fentanyl may lead to increases of bile duct pressure and in isolated cases spasms of the Sphincter of Oddi might be observed.

Intestinal Motility

As with other opioids, fentanyl can have an inhibitory effect on intestinal motility. This should be considered in the pain management of intensive care patients with inflammatory or obstructive intestinal diseases.

Serotonin Syndrome

Caution is advised when fentanyl is coadministered with drugs that affect the serotonergic neurotransmitter systems.

The development of a potentially life-threatening serotonin syndrome may occur with the concomitant use of serotonergic drugs such as Selective Serotonin Re-uptake Inhibitors (SSRIs) and Serotonin Norepinephrine Re-uptake Inhibitors (SNRIs), and with drugs which impair metabolism of serotonin (including Monoamine Oxidase Inhibitors [MAOIs]). This may occur within the recommended dose.

Serotonin syndrome may include mental-status changes (e.g., agitation, hallucinations, coma), autonomic instability (e.g., tachycardia, labile blood pressure, hyperthermia), neuromuscular abnormalities (e.g., hyperoreflexia, incoordination, rigidity), and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhoea).

If serotonin syndrome is suspected, rapid discontinuation of fentanyl should be considered.

Paediatric Population

Techniques that involve analgesia in a spontaneously breathing child should only be used as part of an anesthetic technique, or given as part of a sedation / analgesia technique, with experienced personnel in an environment that can manage sudden chest wall rigidity requiring intubation, or apnea requiring airway support.

Legal Considerations

Legal Status of Fentanyl Citrate in Different Regions

The legality of Fentanyl Citrate varies by country.

Import Regulations and Customs Procedures

If purchasing from an international source, be aware of import regulations and customs procedures. Ensure the online pharmacy complies with these regulations to avoid legal issues and delivery problems.